Healthcare

Will Clarity Pharmaceuticals' Imaging Agent Change Prostate Cancer D...
February 19, 2025 01:31 PM AEDT | By Team Kalkine MediaHighlights,FDA fast-track designation for prostate cancer imaging agent.,Innovation in dual-targeted bisPSMA technology developed in Australian labora...

Why Cyclopharm's (ASX:CYC) Cash Burn Isn't a Major Concern for Us
February 19, 2025 11:32 AM AEDT | By Team Kalkine MediaHighlights,Cyclopharm's cash reserves suggest a stable runway for growth.,Analyst forecasts indicate potential for cashflow breakeven soon.,Market cap...

How Are ASX-Listed Healthcare Companies Advancing Cancer Diagnostics...
February 19, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights:,Imagion Biosystems is leading the charge in cancer diagnostics with its MagSense platform for HER2+ breast cancer.,Noxopharm focuses on in...

Biocurious: As Mayne Pharmaceuticals faces a takeover bid, who might...
February 19, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights:,Acquisition Momentum:,The agreement for Mayne Pharma to be acquired by Cosette has brought attention to the broader ASX biotech space, hig...

Little Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation i...
February 18, 2025 01:33 PM AEDT | By Team Kalkine MediaLittle Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector

HMC Capital Considers Healthscope Acquisition with Focus on Workforc...
February 18, 2025 12:04 PM AEDT | By Team Kalkine MediaHighlights:,HMC Capital explores a potential acquisition of Healthscope, aiming to,maintain,operational stability.,The company,seeks,to minimise facil...

Health Check: It's Time to Showcase Our Three Local Heroes
February 18, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights:,Nanosonics prepares to introduce Coris, a new anti-infection device designed for hospital instrument cleaning.,Cogstate experiences revenu...

Health Check: Brokers Reduce Cochlear Valuations as Customers Delay...
February 18, 2025 11:00 AM AEDT | By Team Kalkine MediaBiotech Industry Update: Key Developments and Trials

Recce Pharmaceuticals Advances in Fight Against Skin Infections with...
February 17, 2025 10:18 PM AEDT | By Team Kalkine MediaHighlights:,Positive results from Phase II trial of Recce 327 topical gel,No serious adverse events reported, meeting all safety and efficacy endpoint...

ASX Closes Lower as (ASX:AD8) Surges 26% and (ASX:BEN) Faces Sharp D...
February 17, 2025 06:11 PM AEDT | By Team Kalkine MediaHighlights,(ASX:AD8) jumps 26% after strong half-year results,(,ASX:BEN,) slides 15% on weaker margins and earnings shortfall,Seven sectors end in the...

Sonic Healthcare (ASX:SHL): A Closer Look at Stock Performance and L...
February 17, 2025 04:17 PM AEDT | By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) sees a 10% rise in,quarterly,share price.,Shareholder,return over the past three years shows a 23% decline.,Dividend...

Recce Pharmaceuticals Shows Promising Results for Topical Gel in Tre...
February 17, 2025 03:20 PM AEDT | By Team Kalkine MediaHighlights,Recce Pharmaceuticals’ Phase II clinical trial of its topical gel, RECCE 327 (R327G), achieved a 93% primary efficacy endpoint in treating...

Recce Pharmaceuticals (ASX:RCE) Advances R327G to Phase III After Po...
February 17, 2025 01:12 PM AEDT | By Team Kalkine MediaHighlights:,93% Efficacy Rate:,Recce Pharmaceuticals (ASX:RCE) reported that R327G achieved a 93% primary efficacy endpoint in its Phase II trial for...

Althea Group’s Expansion into the North American THC Beverage Market
February 17, 2025 12:30 PM AEDT | By Team Kalkine MediaCannabis in a Can: Nanocap Althea Secures $4M to Boost THC Beverage Expansion in the US and Canada

Recce Pharmaceuticals (ASX:RCE) Advances ABSSSI Treatment with Posit...
February 17, 2025 11:30 AM AEDT | By Team Kalkine MediaBreakthrough in Infection Treatment: Recce Pharmaceuticals (ASX:RCE) Reports Strong Clinical Results

Health Check: After treating its final patient, Opthea anticipates t...
February 17, 2025 11:00 AM AEDT | By Team Kalkine MediaBiotech Developments and Market Movements in Focus

Imugene is well-funded and on the brink of revolutionizing cancer im...
February 17, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights:,Imugene is advancing three immunotherapy programs focused on CAR-T therapies and oncolytic viruses.,The company secured new funding throug...

Will ASX:ARX Reinvent Its Course in a Rapidly Expanding Sector?
February 16, 2025 11:30 AM AEDT | By Team Kalkine MediaHighlights,ASX:ARX experienced a sharp decline in share price, erasing earlier gains.,The company’s price-to-sales ratio remains much lower compared t...

CSL's Earnings for the First Half of 2025: EPS Falls Short of Expect...
February 16, 2025 11:30 AM AEDT | By Team Kalkine MediaHighlights:,CSL Limited (ASX:CSL) reported an increase in revenue in its latest financial results.,Earnings per share came in below expectations despi...

Can Imagion Biosystems Transform HER2 Imaging for Cancer Diagnostics...
February 16, 2025 11:00 AM AEDT | By Team Kalkine MediaHighlights,• MagSense HER2 imaging agent manufacturing commences for advanced clinical trials.,• Innovative imaging technology aims to enhance cancer...